NRXP · NRX Pharmaceuticals, Inc. · Documents
$2.63
+0.01 (+0.38%)
At close · Oct 21
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“the Company has concluded that substantial doubt exists about the Company's ability to continue as a going concern for a period of at least twelve months from the date of issuance of these consolidated financial statements.”View the 10-Q filed Aug 14, 2026
Market Cap
$113.43M
Shares
43.30M
Volume · Oct 21
526.55K
Avg daily vol (3M)
874.71K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2023-09-01 | 2023-08-28 | |
| 8-K | — | 2023-08-31 | — | |
| 10-Q | — | 2023-08-14 | 2023-06-30 | |
| 8-K | — | 2023-08-14 | — | |
| 8-K | — | 2023-07-28 | 2023-07-07 | |
| 8-K/A | — | 2023-06-07 | 2023-06-06 | |
| 8-K | — | 2023-06-06 | — | |
| 8-K | — | 2023-06-05 | 2023-06-02 | |
| 10-K/A | — | 2023-05-26 | 2022-12-31 | |
| 10-Q | — | 2023-05-15 | 2023-03-31 | |
| 10-K/A | — | 2023-05-01 | 2022-12-31 | |
| 8-K | — | 2023-04-21 | 2023-04-18 | |
| 10-K | — | 2023-03-31 | 2022-12-31 | |
| 8-K | — | 2023-03-31 | — | |
| 8-K/A | — | 2023-03-14 | 2023-03-09 | |
| 8-K | — | 2023-03-13 | — | |
| 8-K | — | 2023-03-09 | — | |
| 8-K | — | 2023-03-03 | — | |
| 8-K | — | 2023-02-24 | 2023-02-17 | |
| 8-K | — | 2023-02-23 | 2023-02-16 | |
| 8-K | — | 2023-02-13 | — | |
| 8-K | — | 2023-02-02 | — | |
| DEF 14A | — | 2023-01-10 | 2023-02-02 | |
| PRE 14A | — | 2022-12-23 | 2023-02-02 | |
| 10-Q | — | 2022-11-14 | 2022-09-30 | |
| 8-K | — | 2022-11-14 | 2022-11-12 | |
| 8-K | — | 2022-11-09 | 2022-11-04 | |
| 8-K | — | 2022-08-22 | — | |
| 10-Q | — | 2022-08-15 | 2022-06-30 | |
| 10-Q/A | — | 2022-08-12 | 2021-09-30 | |
| 10-Q/A | — | 2022-08-12 | 2021-06-30 | |
| 8-K | — | 2022-08-12 | 2022-08-10 | |
| 8-K | — | 2022-07-28 | 2022-07-22 | |
| 8-K | — | 2022-07-21 | 2022-07-18 | |
| 8-K | — | 2022-07-15 | 2022-07-12 | |
| DEF 14A | — | 2022-06-21 | 2022-07-18 | |
| DEFA14A | — | 2022-06-16 | — | |
| S-3/A | — | 2022-06-14 | — | |
| S-3 | — | 2022-06-09 | — | |
| 8-K | — | 2022-06-08 | 2022-06-06 | |
| 8-K | — | 2022-05-31 | 2022-05-25 | |
| 8-K | — | 2022-05-25 | 2022-05-19 | |
| 10-Q | — | 2022-05-16 | 2022-03-31 | |
| 10-K/A | — | 2022-04-29 | 2021-12-31 | |
| S-1 | — | 2022-04-08 | — | |
| 10-K | — | 2022-03-31 | 2021-12-31 | |
| 8-K | — | 2022-03-18 | 2022-03-15 | |
| 8-K | — | 2022-03-09 | 2022-03-08 | |
| 8-K | — | 2022-02-11 | — | |
| 8-K | — | 2022-02-03 | 2022-02-02 |
Showing 101–150 of 209 filings